Shockwave Medical (SWAV) Tops Q1 EPS by 23c; Guides Higher

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Shockwave Medical (SWAV) Tops Q1 EPS by 23c; Guides Higher

Shockwave Medical Reports First Quarter 2022 Financial Results

May 9, 2022 4:02 PM EDT

SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2022.

Recent Highlights

Recognized revenue of $93.6 million for the first quarter of 2022, representing an increase of 194% from the same period in 2021Received regulatory approval for the Shockwave C2 Coronary IVL Catheter in JapanAnnounced the global commercial availability and launch of the Shockwave M5+... More